JONATHAN DAVID KURTIS
Physician at Claverick St, Providence, RI
License number
Rhode Island MD10455
Issued Date
Oct 19, 2000
Expiration Date
Jun 30, 2018
Category
Physician
Type
Allopathic Physician (MD)
Address
Address
55 Claverick St RM 325, Providence, RI 02903
Phone
(401) 444-7375 (Work)
(401) 444-7854 (Fax)
(401) 444-7854 (Fax)
Professional information
Dr. Jonathan Kurtis, Providence RI - MD (Doctor of Medicine)
Specialties:
Blood Banking & Transfusion Medicine
Address:
Rhode Island Hospital-PTH
593 Eddy St, Providence 02903
(401) 444-5151 (Phone)
593 Eddy St, Providence 02903
(401) 444-5151 (Phone)
Certifications:
Blood Bank & Transfusion Medicine, 2001, Clinical Pathology, 2000
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Rhode Island Hospital-PTH
593 Eddy St, Providence 02903
Miriam Hospital
164 Summit Ave, Providence 02906
Rhode Island Hospital
593 Eddy St, Providence 02903
593 Eddy St, Providence 02903
Miriam Hospital
164 Summit Ave, Providence 02906
Rhode Island Hospital
593 Eddy St, Providence 02903
Education:
Medical School
Brown University / Alpert Medical School
Graduated: 1993
Brown University / Alpert Medical School
Graduated: 1993
Jonathan Kurtis, Providence RI
Work:
RHODE ISLAND HOSPITAL
55 Claverick St, Providence, RI 02903
55 Claverick St, Providence, RI 02903
Director, Cihr At Rih
Location:
Providence, Rhode Island Area
Industry:
Biotechnology
Schistosoma Vaccine
US Patent:
2012012, May 24, 2012
Filed:
Nov 5, 2008
Appl. No.:
12/864041
Inventors:
Jonathan Kurtis - Providence RI, US
Mario Jiz - Providence RI, US
Haiwei Wu - Lincoln RI, US
Sunthorn Pond-Tor - Cranston RI, US
Mario Jiz - Providence RI, US
Haiwei Wu - Lincoln RI, US
Sunthorn Pond-Tor - Cranston RI, US
International Classification:
A61K 39/00, A61P 33/00, A61P 37/04, A61K 38/39
US Classification:
4242651, 530353
Abstract:
The method for large scale production of a full length Schistosomal paramyosin coiled coil dimer composition is carried out by providing a composition comprising recombinant paramyosin, contacting the composition with a strand separation agent to remove paramyosin fragments and other contaminants. The purified paramyosin is used in vaccines for humans and bovine animals to induce immunity against schistosomal infection.